- An mRNA containing a premature stop codon is observed to have delayed nuclear export compared to the same mRNA without the premature stop codon. Both mRNAs are properly capped and polyadenylated. What mechanism most likely accounts for this difference in export kinetics?
Answer: Quality control mechanisms detect the premature stop codon and delay export for potential repair
When you encounter questions about mRNA processing and nuclear export, focus on the sophisticated quality control systems that cells use to ensure only properly processed transcripts reach the cytoplasm for translation.
Eukaryotic cells have evolved elegant surveillance mechanisms to detect defective mRNAs before they leave the nucleus. The exon junction complex (EJC) pathway is a key quality control system that can identify premature termination codons (PTCs). When ribosomes encounter a stop codon upstream of an exon-exon junction during the pioneer round of translation in the nucleus, this signals an abnormal transcript. The cell responds by retaining the mRNA in the nucleus, allowing time for potential editing or repair mechanisms to correct the defect before export. This delay protects the cell from producing truncated, potentially harmful proteins.
Answer A is incorrect because nuclear ribosomes don't physically block nuclear pores—the export machinery operates independently of ribosome positioning. Answer B misrepresents the mechanism; while secondary structures can affect mRNA function, premature stop codons are primarily detected through ribosome-mediated surveillance, not structural changes that block export factors. Answer D is wrong because both mRNAs are stated to be properly capped and polyadenylated, indicating normal 3' end processing regardless of internal stop codons.
Remember that mRNA quality control is multilayered—cells invest heavily in proofreading systems because faulty proteins can be more costly than delayed gene expression. Focus on understanding surveillance pathways like nonsense-mediated decay and EJC-dependent quality control when studying RNA processing.
- A researcher observes that inhibition of CRM1, a major nuclear export receptor, blocks export of certain mRNAs but not others. The mRNAs that continue to be exported all encode ribosomal proteins. What is the most likely explanation for this selective effect?
Answer: Ribosomal protein mRNAs are exported through nuclear pores using a different export receptor system
When you encounter questions about nuclear export, remember that different types of RNA molecules use distinct pathways to exit the nucleus, each with specialized machinery adapted to their cellular roles.
Ribosomal protein mRNAs have unique export requirements because they're needed in massive quantities for ribosome assembly. These transcripts use a specialized export pathway that relies on different export receptors than the standard CRM1-dependent system. This parallel export system ensures that ribosomal protein synthesis can continue even when other mRNA export is compromised, reflecting the cell's critical need for continuous ribosome production.
Option A incorrectly suggests that high expression levels alone determine export pathway usage. While ribosomal protein mRNAs are highly expressed, the pathway choice is determined by specific sequence elements and processing features, not expression quantity. Option B confuses export mechanisms with translation initiation - internal ribosome entry sites (IRES) affect how ribosomes bind to mRNA during protein synthesis, not how mRNA exits the nucleus. Option C proposes that different 5' cap structures explain the selective effect, but ribosomal protein mRNAs actually have standard 7-methylguanosine caps like other mRNAs.
The correct answer is D because ribosomal protein mRNAs utilize alternative export receptors (such as members of the exportin family other than CRM1) that recognize specific RNA-binding proteins associated with these transcripts.
For cell biology exams, remember that specialized cellular processes often have backup or alternative pathways, especially for essential functions like ribosome biogenesis. Look for answers that reflect this biological redundancy rather than simple mechanical explanations.
- A mutation in the THO complex, which is involved in mRNA export, causes accumulation of unspliced pre-mRNAs in the nucleus along with defective mRNA export. Why might splicing defects occur when an mRNA export factor is mutated?
Answer: mRNA processing and export are coupled processes that coordinate splicing completion with export competency
When you encounter questions about nuclear processes like mRNA processing and export, remember that these aren't independent events happening in isolation—they're highly coordinated and coupled processes that work together to ensure proper gene expression.
The THO complex is part of a larger machinery called TREX (transcription-export complex) that physically links mRNA processing with nuclear export. This coupling ensures that only properly processed mRNAs are exported to the cytoplasm. When THO is mutated, this coordination breaks down. The cell's quality control mechanisms detect that mRNAs aren't properly packaged for export, which triggers retention of incompletely processed transcripts in the nucleus. This creates a backup that interferes with ongoing splicing reactions, leading to accumulation of unspliced pre-mRNAs. Answer C correctly identifies this coupling relationship.
Answer A is wrong because THO doesn't directly catalyze splicing—that's the spliceosome's job. THO functions downstream of splicing in the export pathway. Answer B incorrectly suggests competition for binding sites, but export and splicing factors work cooperatively, not competitively. Answer D has the directionality backward—splicing factors are already nuclear proteins that don't need cytoplasmic import.
The key insight for cell biology questions is recognizing that nuclear processes are interconnected networks, not separate pathways. When you see a mutation affecting one process but causing defects in another, think about coupling mechanisms that coordinate these processes for quality control and efficiency.
- An mRNA encoding a synaptic protein is found to localize specifically to dendritic spines in neurons, but when the same mRNA is expressed in non-neuronal cells, it remains in the perinuclear region. What factor is most likely responsible for this cell-type specific localization?
Answer: Neuron-specific RNA-binding proteins that recognize localization signals in the mRNA
When you encounter questions about mRNA localization differences between cell types, focus on the specialized machinery that controls where mRNAs travel within cells. mRNA localization is a crucial mechanism for spatially restricting protein synthesis, especially important in highly polarized cells like neurons.
The correct answer is C because neuron-specific RNA-binding proteins are the key determinants of mRNA localization. These proteins recognize specific sequence elements (called localization signals or "zip codes") within the mRNA's 3' untranslated region. In neurons, these RNA-binding proteins form ribonucleoprotein complexes that actively transport mRNAs along cytoskeletal tracks to dendritic spines. Non-neuronal cells lack these specialized transport proteins, so the same mRNA remains near the nucleus where translation typically occurs.
Option A is incorrect because nuclear export receptors don't modify mRNA structure or determine cytoplasmic localization patterns. Option B misrepresents ribosome function—ribosomes don't vary significantly between cell compartments or recognize localization sequences. The ribosome's job is protein synthesis, not mRNA transport. Option D suggests alternative splicing creates the difference, but the question states it's the same mRNA in both cell types, ruling out splicing variants as the explanation.
Remember that mRNA localization questions often test whether you understand the distinction between the mRNA transport machinery (RNA-binding proteins and motor complexes) versus the protein synthesis machinery (ribosomes). Focus on which cellular components are actually responsible for moving mRNAs to specific locations.
- In a cell-free system, purified mRNPs (messenger ribonucleoprotein particles) from the nucleus can bind to nuclear pore complexes but cannot complete export unless cytoplasmic extracts are added. What component of the cytoplasmic extract is most likely required?
Answer: Ran-GAP (GTPase activating protein) required for Ran-GTP hydrolysis and cargo release
Nuclear export questions test your understanding of the Ran-GTP gradient system that drives nucleocytoplasmic transport. When you see cell-free systems that can bind cargo but can't complete transport, think about what's missing from the normal cellular environment.
The key insight here is that mRNPs can bind to nuclear pores but get stuck there without cytoplasmic extracts. This tells you the export machinery is present and functional, but the cargo release mechanism is broken. Nuclear export depends on the Ran-GTP cycle: export receptors bind cargo in the nucleus (where Ran-GTP is high), travel through the pore, then release cargo in the cytoplasm when Ran-GAP triggers GTP hydrolysis. Without cytoplasmic Ran-GAP, the export receptors remain bound to their cargo even after reaching the cytoplasmic side. Answer B correctly identifies this missing component.
Answer A is wrong because mRNA export occurs independently of translation—ribosomes don't pull mRNAs through pores. Answer C misses the point: the problem isn't mRNA stability after export, but the inability to complete export in the first place. The mRNPs are stuck at the pore. Answer D incorrectly suggests nuclear transport requires ATP, when it actually uses the Ran-GTP gradient as its energy source.
Remember that nuclear transport is powered by the Ran-GTP gradient, not ATP. When you see export problems in cell-free systems, consider what components of the Ran cycle might be missing—usually it's the cytoplasmic factors needed for cargo release.
- An experiment shows that mRNAs containing AU-rich elements (AREs) in their 3' UTRs have shorter half-lives in the cytoplasm compared to mRNAs lacking these elements. However, when nuclear export is blocked, both types of mRNAs show similar stability. What is the most likely explanation?
Answer: Cytoplasmic ARE-binding proteins that promote mRNA degradation cannot access mRNAs retained in the nucleus
When you encounter questions about mRNA stability and subcellular localization, focus on where specific regulatory proteins can access their target mRNAs and under what conditions.
The key insight here is that AU-rich elements (AREs) are recognized by specific binding proteins that promote mRNA degradation, but these proteins are primarily located in the cytoplasm. Under normal conditions, mRNAs with AREs are exported to the cytoplasm where they encounter ARE-binding proteins like AUF1 and tristetraprolin, which recruit degradation machinery and shorten mRNA half-life. When nuclear export is blocked, these cytoplasmic degradation factors cannot access the mRNAs retained in the nucleus, so both ARE-containing and ARE-lacking mRNAs show similar stability. This confirms that answer B is correct - cytoplasmic ARE-binding proteins that promote degradation cannot access nuclear-retained mRNAs.
Answer A is incorrect because ribonucleases involved in ARE-mediated decay are cytoplasmic, not nuclear enzymes that get excluded during export. Answer C reverses the actual mechanism - export doesn't remove protective proteins but rather exposes mRNAs to degradation factors. Answer D is wrong because AREs don't undergo chemical modifications during export that affect their degradation susceptibility; they're recognized by pre-existing protein-binding specificities.
Remember that mRNA stability regulation often depends on the subcellular compartment where the mRNA resides and which regulatory proteins have access to it. Always consider where the relevant binding proteins and enzymes are normally located when analyzing these experimental scenarios.
- An mRNA contains a 3' UTR sequence that binds to a specific protein complex. When this sequence is deleted, the mRNA is exported normally from the nucleus but shows altered subcellular distribution in the cytoplasm. Which process is most directly affected by this deletion?
Answer: Cytoplasmic localization through interaction with motor proteins and cytoskeletal elements
When you encounter questions about mRNA processing and localization, focus on the sequence of events: nuclear processing → nuclear export → cytoplasmic targeting. The key clue here is that nuclear export occurs normally, but cytoplasmic distribution changes when the 3' UTR sequence is deleted.
The 3' untranslated region (UTR) contains regulatory sequences that don't code for protein but control mRNA fate after translation. Since the mRNA exports normally but shows altered subcellular distribution in the cytoplasm, this indicates the deleted sequence was responsible for directing the mRNA to specific cellular locations. This process requires interaction with motor proteins (like kinesin or dynein) that transport mRNAs along cytoskeletal elements (microtubules or actin filaments) to reach destinations like the endoplasmic reticulum or cell periphery.
Answer A is incorrect because nuclear pore complex recognition occurs normally—the question states the mRNA exports properly. Answer B is wrong since nuclear export machinery functions normally, as evidenced by successful mRNA export. Answer D doesn't fit because splicing occurs in the nucleus during pre-mRNA processing, before the 3' UTR would influence cytoplasmic events, and the question focuses on post-export distribution.
The correct answer is C because cytoplasmic localization depends on specific sequences in the 3' UTR that recruit protein complexes containing motor proteins, which then transport the mRNA along cytoskeletal tracks to precise cellular locations.
Remember: 3' UTRs are postal codes for mRNA—they determine where messages go in the cytoplasm, not whether they can leave the nucleus.
- Time-lapse microscopy reveals that an mRNA encoding a mitochondrial protein shows initial uniform distribution in the cytoplasm immediately after nuclear export, but gradually concentrates around mitochondria over several hours. What is the most likely mechanism responsible for this redistribution?
Answer: Active transport of mRNAs to mitochondria via motor proteins recognizing specific RNA sequences
When you encounter questions about mRNA localization patterns, focus on the specific temporal and spatial dynamics described. This question describes a gradual concentration process over hours, which is key to identifying the mechanism.
The correct answer is B because active transport via motor proteins is the primary mechanism for directed mRNA localization in eukaryotic cells. Motor proteins like kinesin and dynein can recognize specific sequences or secondary structures in mRNAs (often in 3' UTRs) and transport them along cytoskeletal tracks to specific cellular locations. This process occurs over the timeframe described (several hours) and explains both the initial uniform distribution and the gradual accumulation around mitochondria. Many mRNAs encoding mitochondrial proteins contain localization signals that direct them to mitochondrial surfaces before translation.
Option A is incorrect because selective degradation would result in mRNA loss rather than redistribution, and you'd see overall signal decrease rather than concentration. Option C is wrong because preferential translation doesn't explain how mRNAs get to mitochondria in the first place - translation efficiency alone cannot drive spatial redistribution. Option D describes a passive process, but simple diffusion and protein interactions wouldn't create the directed, time-dependent accumulation pattern observed.
For cell biology exams, remember that mRNA localization is typically an active, energy-dependent process. When you see gradual accumulation patterns over hours, think motor protein-mediated transport rather than passive diffusion or degradation mechanisms. This is a fundamental principle of cellular organization.
- In neurons, the mRNA for a dendritic protein is found to be exported from the nucleus in a translationally repressed state and only becomes translationally active after reaching dendritic spines. What advantage does this coupling of localization and translation provide?
Answer: It ensures that the protein is synthesized only where it is needed, preventing mislocalization
When you encounter questions about mRNA localization and translational control, think about the cellular economy—cells want to place proteins precisely where they're needed while avoiding waste and potential problems from misplaced proteins.
The correct answer is A because this mechanism provides spatial precision. By keeping the mRNA translationally silent during transport and only activating translation at dendritic spines, neurons ensure the protein is synthesized exactly where it will function. This prevents the protein from being made in inappropriate locations where it might interfere with other processes or simply be wasted. Given that dendritic proteins often have specialized functions at synapses, this precise localization is crucial for proper neuronal signaling.
Let's examine why the other options are incorrect. Option B suggests mRNA protection during transport, but translational repression doesn't inherently protect mRNA from degradation—other mechanisms like RNA-binding proteins and specific mRNA modifications handle stability. Option C proposes location-specific isoform production, but the question describes the same mRNA making the same protein in different amounts, not different variants. Option D focuses on competition between nuclear export and translation, but these processes occur in different cellular compartments and timeframes, so direct competition isn't the primary concern.
For cell biology questions involving mRNA localization, always consider the functional advantage of spatial control. Cells invest considerable energy in transporting mRNAs to specific locations, so the payoff is usually precise protein placement that supports specialized cellular functions.
- A mutation in exportin-1 (CRM1) causes it to bind normally to cargo and Ran-GTP in the nucleus but show reduced affinity for nucleoporins. What would be the expected effect on mRNA export through this pathway?
Answer: Export complexes would form normally but show reduced efficiency in nuclear pore translocation
When you encounter questions about nuclear transport, focus on the sequential steps: cargo loading, transport complex formation, nuclear pore transit, and cargo release. Each step requires specific molecular interactions, and disrupting any one step affects the overall process differently.
Exportin-1 (CRM1) mediates mRNA export through a well-defined mechanism. In the nucleus, CRM1 binds its cargo (mRNA-protein complexes) and Ran-GTP to form a stable export complex. This complex then interacts with nucleoporins—the proteins that line nuclear pores—to facilitate translocation through the pore. Once in the cytoplasm, Ran-GTP is hydrolyzed, causing cargo release.
The mutation described allows normal cargo binding and Ran-GTP association, so export complexes form properly. However, reduced nucleoporin affinity impairs the complex's ability to efficiently navigate through nuclear pores. The complexes can still transit, but less effectively, resulting in reduced export efficiency rather than complete blockade.
Option A is incorrect because cargo loading occurs normally—the mutation doesn't affect CRM1's cargo-binding domain. Option C misunderstands the role of nucleoporin binding; these interactions are essential for guided pore transit, not obstacles to overcome. Option D ignores the critical role nucleoporins play in facilitating transport through the selective barrier of nuclear pores.
Remember that nuclear transport is a multi-step process where each molecular interaction serves a specific purpose. Partial defects typically reduce efficiency rather than completely blocking transport, unlike complete loss-of-function mutations that would eliminate entire steps.
- Researchers find that an mRNA encoding a membrane protein is specifically localized to the endoplasmic reticulum, while the same mRNA with its 3' UTR replaced by that of a cytosolic protein becomes uniformly distributed throughout the cytoplasm. What can be concluded about mRNA localization mechanisms?
Answer: The 3' UTR contains cis-acting elements that recruit trans-acting factors for subcellular localization
When you encounter questions about mRNA localization, focus on the distinction between co-translational targeting (which occurs during translation) and mRNA localization (which occurs before translation begins).
The experimental evidence clearly points to answer B. The researchers swapped only the 3' UTR between two mRNAs and observed a complete change in localization pattern - from ER-specific to cytoplasm-wide distribution. This demonstrates that the 3' UTR contains cis-acting elements (specific RNA sequences) that recruit trans-acting factors (proteins that bind to these sequences) to direct the mRNA to its proper subcellular location before translation starts.
Answer A is incorrect because co-translational targeting relies on the signal recognition particle recognizing the signal sequence as it emerges from the ribosome during translation - this process doesn't depend on 3' UTR sequences. Answer C misrepresents the mechanism; mRNAs aren't prevented from translating until they reach their destination, rather they're actively transported to where their protein products are needed. Answer D is wrong because while RNA secondary structure can affect function, the experiment specifically demonstrates that sequence elements (not just structural changes) in the 3' UTR are responsible, since swapping UTRs from functionally different proteins caused the localization change.
Remember that 3' UTRs are major regulatory regions containing binding sites for proteins and microRNAs that control mRNA fate - including where the mRNA goes, when it's translated, and how long it persists in the cell.
- A researcher finds that mRNAs injected into Xenopus oocytes are exported from the nucleus more slowly than endogenous oocyte mRNAs, even though both types of mRNAs have similar cap and poly(A) tail structures. What factor most likely accounts for this difference?
Answer: Endogenous mRNAs have co-transcriptionally assembled protein complexes that facilitate export
When you encounter questions about mRNA nuclear export, focus on the co-transcriptional assembly process—the idea that protein complexes bind to mRNA during transcription to prepare it for export.
Endogenous mRNAs undergo co-transcriptional assembly, meaning that as they're transcribed in the nucleus, various protein complexes automatically bind to them. These include the exon junction complex (EJC), cap-binding complex, and export factors like TAP/NXF1. This creates a properly assembled ribonucleoprotein (RNP) particle that's primed for efficient nuclear export. The injected mRNAs, however, bypass this natural assembly process—they arrive in the nucleus as "naked" RNA molecules that must recruit export machinery post-transcriptionally, which is much less efficient.
Choice A is incorrect because nuclear export receptors aren't pre-bound to specific mRNAs; they're recruited during the export process. Choice C misses the point—this isn't about competition for nuclear pores, since both mRNA types eventually export, just at different rates. Choice D is wrong because the question states both mRNA types have similar cap and poly(A) structures, and Xenopus oocytes are commonly used precisely because they can process foreign mRNAs effectively.
The key insight is that transcription and mRNA processing are coupled processes. Export efficiency depends not just on having the right sequence elements (caps and tails), but on having the proper protein machinery assembled in the right temporal order during mRNA biogenesis.
Remember: co-transcriptional assembly is crucial for efficient mRNA export—it's not just about the RNA sequence, but about the protein complexes that travel with it.
- Researchers discover that certain viral mRNAs can be exported from the nucleus even when cellular mRNA export is severely impaired by drug treatment. Analysis reveals these viral mRNAs lack exon junction complexes (EJCs). How might the absence of EJCs contribute to continued viral mRNA export?
Answer: Viral mRNAs use EJC-independent export pathways that remain functional during drug treatment
When you encounter questions about differential RNA processing or export between viral and cellular systems, focus on how viruses exploit alternative cellular pathways to overcome host defenses or drug treatments.
Viral mRNAs that lack exon junction complexes (EJCs) can utilize EJC-independent export mechanisms that remain functional when conventional cellular export is blocked. Normal cellular mRNAs acquire EJCs during splicing, and these complexes help recruit export factors like the TREX complex for nuclear export. However, cells also possess alternative export pathways that don't rely on EJCs. Many viral mRNAs, particularly those that are unspliced or use different processing mechanisms, can access these backup pathways. When drug treatment targets the primary EJC-dependent export machinery, viral mRNAs continue exiting the nucleus through these alternative routes, explaining their continued export despite impaired cellular mRNA transport.
Option A incorrectly suggests competition between EJCs and viral factors at nuclear pores, but EJCs actually facilitate rather than compete with export machinery. Option C mischaracterizes the drug's mechanism—the drugs likely target export factors or nuclear pore components, not EJCs themselves, since EJCs are normally beneficial for export. Option D confuses export mechanisms with quality control; while EJCs do participate in nonsense-mediated decay surveillance, the question specifically addresses export during active drug treatment, not quality control evasion.
Remember that viruses often exploit redundant cellular pathways that remain functional when primary systems are compromised, making them remarkably adaptable to various cellular stresses or treatments.
- A cell line deficient in nuclear poly(A) binding protein (PABP) shows normal mRNA processing but severely reduced mRNA export. However, when cytoplasmic PABP is artificially introduced into the nucleus, export is restored. What does this suggest about the role of PABP in mRNA export?
Answer: Nuclear PABP is required for proper mRNA packaging into export-competent ribonucleoprotein particles
When you encounter questions about mRNA export defects that can be rescued by protein substitution, focus on what the rescue tells you about the protein's specific function in the pathway.
The key insight here is that cytoplasmic PABP can restore export function when introduced to the nucleus, even though it's not normally found there. This suggests that PABP's role in export isn't location-specific but rather functional—it must be providing a structural or organizational role that can work regardless of which cellular compartment the PABP originally came from. Since mRNA processing remains normal, PABP isn't needed for the chemical modifications of mRNA, but rather for organizing the processed mRNA into the proper three-dimensional structure required for export. This points directly to answer B: nuclear PABP helps package mRNA into export-competent ribonucleoprotein particles.
Answer A is incorrect because if PABP directly interacted with nuclear pore proteins, you'd expect the interaction to be highly specific to nuclear PABP, and cytoplasmic PABP likely wouldn't substitute effectively. Answer C fails because the experiment shows normal processing, indicating the mRNA isn't being degraded—the problem is specifically with export. Answer D is wrong because cap-binding complex recruitment typically occurs early in processing, and since processing is normal in these cells, this step is clearly functioning properly.
Remember: when analyzing rescue experiments, the source of the rescuing protein often reveals whether the function is location-specific (biochemical interaction) or structural (organizational role).
- A researcher observes that mRNAs encoding ribosomal proteins accumulate in the cytoplasm but fail to associate with ribosomes when cells are treated with a compound that disrupts the nuclear pore complex. However, when the same mRNAs are microinjected directly into the cytoplasm, they translate normally. What is the most likely explanation for this observation?
Answer: Nuclear export disruption prevents acquisition of cytoplasmic translation factors required for ribosome binding
When you encounter questions about nuclear-cytoplasmic transport and translation, focus on the sequential steps required for mRNA function and where each process occurs.
The key insight here is that the microinjected mRNAs translate normally, indicating the mRNAs themselves are structurally intact. This tells you the problem isn't with the mRNA modifications but rather with the export process itself. During normal nuclear export, mRNAs don't just passively move through nuclear pores—they acquire essential protein factors that remain bound and facilitate subsequent cytoplasmic processes, including ribosome recruitment.
When nuclear pore complexes are disrupted, mRNAs that eventually reach the cytoplasm have bypassed the normal export machinery and lack these critical associated factors. Without proper export-dependent protein binding, the mRNAs cannot efficiently recruit ribosomes, even though they're structurally sound. The microinjection experiment proves this because it delivers intact, translatable mRNAs directly to their destination.
Looking at the wrong answers: (A) is incorrect because 5' capping occurs during transcription in the nucleus, and disrupted export wouldn't affect this earlier step. (C) fails because polyadenylation also happens in the nucleus before export, and the microinjection control shows the mRNAs are functional. (D) is wrong since splicing precedes export, and again, the successful microinjection demonstrates the mRNAs are properly processed.
Remember: when you see transport inhibition experiments with rescue controls, consider not just the cargo's integrity but also the cellular machinery and factors that normally accompany proper trafficking.
- A cell line is engineered to express a mutant form of Ran-GTP that cannot be hydrolyzed to Ran-GDP. What would be the expected effect on mRNA export from the nucleus?
Answer: mRNA export would be blocked because export receptors cannot release their cargo in the cytoplasm
When you encounter questions about nuclear transport, focus on the Ran-GTP/GDP cycle and how it drives the directionality of import and export processes. The key insight is that Ran-GTP and Ran-GDP have opposite effects on cargo binding to transport receptors.
For mRNA export, the process works like this: Export receptors (like Crm1) bind their mRNA cargo in the nucleus where Ran-GTP concentrations are high. The Ran-GTP actually helps stabilize this export complex. The complex then moves through nuclear pores to the cytoplasm, where Ran-GTP is hydrolyzed to Ran-GDP by cytoplasmic factors. This hydrolysis causes a conformational change that reduces the export receptor's affinity for its cargo, allowing mRNA release.
If Ran-GTP cannot be hydrolyzed as described in this mutant, export receptors would remain locked in their high-affinity state even in the cytoplasm. They couldn't release their mRNA cargo, making answer B correct.
Answer A is wrong because while Ran-GTP does stabilize export complexes, the inability to hydrolyze it prevents cargo release, blocking rather than increasing export. Answer C incorrectly suggests Ran-GTP hydrolysis only matters for protein import—it's actually essential for both import and export processes. Answer D is backwards; Ran-GTP binding to export receptors is required, not problematic.
Remember: nuclear transport relies on the Ran-GTP gradient and hydrolysis cycle. If you can't complete the cycle, you can't complete the transport process, regardless of whether it's import or export.
- A fluorescently-labeled mRNA injected into the nucleus of a living cell shows rapid export to the cytoplasm, but the same mRNA injected without its 5' cap structure remains in the nucleus. However, when cap-binding complex (CBC) is depleted from cells, both capped and uncapped mRNAs are retained in the nucleus. What role does the CBC play in mRNA export?
Answer: CBC is required for recruiting export factors to mRNAs regardless of their cap status
When you encounter questions about mRNA nuclear export, focus on the sequential steps and protein factors required for this essential cellular process. The experimental design here is key—it compares normal conditions, cap-depleted mRNA, and CBC-depleted cells to isolate the CBC's specific function.
The correct answer is B because CBC serves as a universal recruitment platform for export machinery. Even though uncapped mRNA normally can't exit the nucleus, the experiment shows that when CBC is depleted, both capped and uncapped mRNAs are retained. This tells you that CBC's role extends beyond just cap recognition—it's essential for recruiting export factors regardless of whether the mRNA has a cap structure.
Answer A is incorrect because CBC doesn't directly interact with nucleoporins; instead, it recruits export receptors that then engage the nuclear pore machinery. Answer C misidentifies CBC's primary function—while nuclear protection might be a secondary benefit, the retention of both mRNA types when CBC is depleted points to an export defect, not degradation. Answer D is wrong because mRNA folding isn't the limiting factor here; if it were, you'd expect some export even without CBC, just at reduced efficiency.
Remember that nuclear export questions often test your understanding of protein recruitment cascades rather than direct transport mechanisms. Look for experimental evidence that distinguishes between direct transport roles versus recruitment/scaffolding functions—the retention of both mRNA types when CBC is absent is a classic sign of a recruitment factor.
- Cells treated with actinomycin D, which blocks transcription, show continued mRNA export for several hours after treatment. However, when both actinomycin D and a nuclear export inhibitor are added simultaneously, mRNA levels in the cytoplasm decrease more rapidly than with export inhibition alone. What does this suggest about mRNA export dynamics?
Answer: There is a nuclear pool of processed mRNAs that continues to be exported after transcription stops
When you encounter questions about transcription inhibitors and mRNA dynamics, think about the temporal separation between transcription, processing, and export. These processes don't happen instantaneously, creating pools of mRNA at different stages.
The key insight here is understanding what happens to already-transcribed mRNA when new transcription stops. Actinomycin D blocks RNA polymerase II from making new transcripts, but it doesn't affect mRNAs that were already synthesized, processed, and waiting in the nucleus for export. The continued export for hours after treatment demonstrates this nuclear reservoir of processed mRNAs gradually emptying into the cytoplasm.
The simultaneous treatment experiment clinches this interpretation: when export is blocked alongside transcription inhibition, cytoplasmic mRNA drops faster than with export inhibition alone because you're preventing the nuclear pool from replenishing cytoplasmic levels while normal mRNA degradation continues.
Answer choice A incorrectly suggests actinomycin D affects degradation pathways rather than simply blocking new transcript synthesis. Choice B misinterprets the data—if coupling were required for stability, you wouldn't see continued export after transcription stops. Choice D proposes an indirect mechanism involving import of protective factors, but this doesn't explain why blocking export specifically accelerates the cytoplasmic mRNA decline.
For cell biology questions involving inhibitors, always consider the timing and compartmentalization of cellular processes. Think about what pools of molecules already exist when an inhibitor is added—often the immediate effects reveal these normally invisible reservoirs.
- An mRNA encoding a secreted protein contains two different localization signals in its 3' UTR: one that directs it to the endoplasmic reticulum and another that targets it to mitochondria. In normal cells, this mRNA is found predominantly at the ER. However, when ER stress occurs, the same mRNA redistributes to mitochondria. What mechanism most likely explains this relocalization?
Answer: Stress-induced changes in RNA-binding protein expression alter the relative strength of competing localization signals
This question tests your understanding of post-transcriptional regulation, specifically how cells dynamically control mRNA localization through competing RNA-binding proteins. When you see a question about mRNA relocalization under stress conditions, think about how cellular stress often triggers changes in protein expression that can shift the balance of regulatory mechanisms.
Under normal conditions, this mRNA localizes to the ER because ER-targeting RNA-binding proteins outcompete mitochondrial-targeting proteins for binding sites in the 3' UTR. During ER stress, cells activate stress response pathways that alter gene expression, changing the relative amounts of these competing RNA-binding proteins. This shift in protein levels tips the balance toward mitochondrial localization signals, causing the mRNA to redistribute. This represents a sophisticated cellular mechanism to redirect protein synthesis away from a stressed organelle.
Let's examine why the other options don't work: (A) is incorrect because the question states this occurs with the same mRNA containing both signals - alternative splicing would create different mRNA variants, not relocalize existing ones. (C) misunderstands the process since mRNA localization occurs in the cytoplasm after nuclear export is already complete. (D) suggests masking rather than competition, but the mechanism described involves active competition between different RNA-binding proteins, not simple masking and unmasking.
Remember that post-transcriptional regulation often involves competition between regulatory proteins. When studying mRNA processing and localization, focus on how stress conditions commonly alter the expression levels of regulatory proteins, shifting the balance of competing pathways rather than completely blocking specific mechanisms.
